已發(fā)表的部分文獻(xiàn): 標(biāo)題:Proteasome activator REGgamma enhances coxsackieviral infection by facilitating p53 degradation.作者:Gao G, Wong J, Zhang J, Mao I, Shravah J, Wu Y, Xiao A, Li X, Luo H;雜志名稱:J Virol 標(biāo)題:Aberrant sumoylation signaling evoked by reactive oxygen species impairs protective function of Prdx6 by destabilization and repression of its transcription.作者:Chhunchha B, Fatma N, Kubo E, Singh DP;雜志名稱:FEBS J 標(biāo)題:Sumoylation-deficient Prdx6 gains protective function by amplifying enzymatic activity and stability and escapes oxidative stress-induced aberrant Sumoylation.作者:Chhunchha B, Kubo E, Fatma N, Singh DP;雜志名稱:Cell Death Dis 標(biāo)題:Ginkgolic Acid Rescues Lens Epithelial Cells from Injury Caused by Redox Regulated-Aberrant Sumoylation Signaling by Reviving Prdx6 and Sp1 Expression and Activities.作者:Chhunchha B, Singh P, Singh DP, Kubo E;雜志名稱:Int J Mol Sci 標(biāo)題:Fyn interrupts telomere maintenance in stem cells by phosphorylating menin at tyrosine 603作者:Paul, S. et. al.;雜志名稱:Research Square 標(biāo)題:Fyn-mediated phosphorylation of Menin disrupts telomere maintenance in stem cells.作者:Paul S, McCourt PM, Le LTM, Ryu J, Czaja W, Bode AM, Contreras-Galindo R, Dong Z;雜志名稱:bioRxiv Epigentek 公司是全球領(lǐng)先的表觀遺傳學(xué)相關(guān)研究的技術(shù)創(chuàng)新者和產(chǎn)品開發(fā)供應(yīng)商。開發(fā)了超過700多個專利產(chǎn)品,為表觀遺傳學(xué)方面的研究和新藥研發(fā)提供全面系統(tǒng)的解決方案,涵蓋樣品制備、DNA/RNA甲基化(5-mc, 5-hmc, 5-fc, m6A)/DNMT分析、ChIP、組蛋白甲基化/乙酰化/去乙酰化/磷酸化/SUMO-等領(lǐng)域,提供小分子抑制劑、蛋白質(zhì)、抗體、以及分析試劑盒產(chǎn)品。